These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2122541

  • 1. Single chain-urokinase binds to oxidized fibrin(ogen) derivatives.
    Stief TW, Martin E, Digon J, Martin-Noya A, Parody R, Rodriguez JM.
    Thromb Res; 1990 Jul 15; 59(2):351-61. PubMed ID: 2122541
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J, Yu M, Ru B.
    Biochim Biophys Acta; 2001 Apr 07; 1546(2):399-405. PubMed ID: 11295444
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
    Fischer BE.
    Blood Coagul Fibrinolysis; 1992 Feb 07; 3(1):39-46. PubMed ID: 1320415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
    Pannell R, Gurewich V.
    Blood; 1986 May 07; 67(5):1215-23. PubMed ID: 3083889
    [Abstract] [Full Text] [Related]

  • 10. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D.
    Thromb Haemost; 1992 Aug 03; 68(2):170-9. PubMed ID: 1412163
    [Abstract] [Full Text] [Related]

  • 11. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin.
    Stief TW, Martín E, Jimenez J, Digón J, Rodriguez JM.
    Thromb Res; 1991 Feb 01; 61(3):191-200. PubMed ID: 1827545
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
    Fleury V, Lijnen HR, Anglés-Cano E.
    J Biol Chem; 1993 Sep 05; 268(25):18554-9. PubMed ID: 8103046
    [Abstract] [Full Text] [Related]

  • 13. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.
    Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E.
    Circulation; 1990 Jun 05; 81(6):1974-80. PubMed ID: 2111744
    [Abstract] [Full Text] [Related]

  • 14. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N.
    Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727
    [Abstract] [Full Text] [Related]

  • 15. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW, Stief MH, Ehrenthal W, Darius H, Martin E.
    Thromb Res; 1991 Dec 01; 64(5):597-610. PubMed ID: 1808764
    [Abstract] [Full Text] [Related]

  • 16. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC, Lijnen HR, Collen D.
    J Biol Chem; 1986 Dec 25; 261(36):17120-6. PubMed ID: 3097021
    [Abstract] [Full Text] [Related]

  • 17. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin.
    Abercrombie DM, Buchinski B, Salvato KA, Vovis GF, Stump DC, Broeze RJ.
    Thromb Haemost; 1990 Nov 30; 64(3):426-32. PubMed ID: 2128973
    [Abstract] [Full Text] [Related]

  • 18. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET, Mack DL, Sobel BE.
    Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679
    [Abstract] [Full Text] [Related]

  • 19. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M, Zenker M, Gaffney PJ.
    Thromb Res; 2000 Nov 15; 100(4):341-51. PubMed ID: 11113278
    [Abstract] [Full Text] [Related]

  • 20. Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin.
    Stief TW.
    Blood Coagul Fibrinolysis; 1993 Feb 15; 4(1):117-21. PubMed ID: 8457638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.